These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30009411)

  • 1. Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence.
    Guichet PO; Masliantsev K; Tachon G; Petropoulos C; Godet J; Larrieu D; Milin S; Wager M; Karayan-Tapon L
    J Pathol; 2018 Oct; 246(2):205-216. PubMed ID: 30009411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary morphogenesis protein 2 is a novel prognostic biomarker and plays oncogenic roles in glioma.
    Tan J; Liu M; Zhang JY; Yao YL; Wang YX; Lin Y; Song K; Tan J; Wu JR; Cui YH; Wang Y; Bian XW
    J Pathol; 2018 Jun; 245(2):160-171. PubMed ID: 29473166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher YAP1 Levels Are Associated With Shorter Survival of Patients With Low Grade Astrocytoma.
    Dicke J; Hero L; Kuhl S; Görtz L; Goldbrunner R; Timmer M
    Anticancer Res; 2024 Jul; 44(7):3005-3011. PubMed ID: 38925840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Yes-associated protein 1 in gliomas: pathologic and therapeutic aspects.
    Liu YC; Wang YZ
    Tumour Biol; 2015 Apr; 36(4):2223-7. PubMed ID: 25750037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.
    Xie Y; Sundström A; Maturi NP; Tan EJ; Marinescu VD; Jarvius M; Tirfing M; Jin C; Chen L; Essand M; Swartling FJ; Nelander S; Jiang Y; Uhrbom L
    J Pathol; 2019 Feb; 247(2):228-240. PubMed ID: 30357839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of YAP1 and pSTAT3-S727 and their prognostic value in glioma.
    Sang W; Xue J; Su LP; Gulinar A; Wang Q; Zhai YY; Hu YR; Gao HX; Li X; Li QX; Zhang W
    J Clin Pathol; 2021 Aug; 74(8):513-521. PubMed ID: 33020176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics reveals protein phosphatase 1γ as a biomarker associated with Hippo signal pathway in glioma.
    Xue J; Sang W; Su LP; Gao HX; Cui WL; Abulajiang G; Wang Q; Zhang J; Zhang W
    Pathol Res Pract; 2020 Nov; 216(11):153187. PubMed ID: 32919304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
    Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U
    Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
    Lvu W; Fei X; Chen C; Zhang B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors.
    Aguennouz M; Polito F; Visalli M; Vita G; Raffa G; Oteri R; Ghazi B; Scalia G; Angileri FF; Barresi V; Caffo M; Cardali S; Conti A; Macaione V; Bartolotta M; Giorgio RD; Germanò A
    Cancer Treat Res Commun; 2020; 24():100203. PubMed ID: 32777750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
    Qian F; Xiao J; Gai L; Zhu J
    Mol Carcinog; 2019 Apr; 58(4):500-510. PubMed ID: 30456802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-622 suppresses the proliferation of glioma cells by targeting YAP1.
    Xu J; Ma B; Chen G; Wei D; Li L; Hu W
    J Cell Biochem; 2018 Mar; 119(3):2492-2500. PubMed ID: 28796324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism.
    Dixit D; Ghildiyal R; Anto NP; Sen E
    Cell Death Dis; 2014 May; 5(5):e1212. PubMed ID: 24810048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing OLIG2 function in tumorigenicity and plasticity to target malignant gliomas.
    Kosty J; Lu F; Kupp R; Mehta S; Lu QR
    Cell Cycle; 2017 Sep; 16(18):1654-1660. PubMed ID: 28806136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas.
    Liu M; Lin Y; Zhang XC; Tan YH; Yao YL; Tan J; Zhang X; Cui YH; Liu X; Wang Y; Bian XW
    Lab Invest; 2017 Nov; 97(11):1354-1363. PubMed ID: 28759011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of perivascular tumour cells defined by CD109 expression in progression of glioma.
    Shiraki Y; Mii S; Enomoto A; Momota H; Han YP; Kato T; Ushida K; Kato A; Asai N; Murakumo Y; Aoki K; Suzuki H; Ohka F; Wakabayashi T; Todo T; Ogawa S; Natsume A; Takahashi M
    J Pathol; 2017 Dec; 243(4):468-480. PubMed ID: 28888050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of transcriptional coactivator TAZ in gliomas.
    Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
    Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
    Di K; Linskey ME; Bota DA
    Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.